Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. Over the past months, considerable efforts have been put into developing effective and safe drugs and vaccines against SARS-CoV-2. Various platforms are being used...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldo, Aline, Leunda, Amaya, Willemarck, Nicolas, Pauwels, Katia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147846/
https://www.ncbi.nlm.nih.gov/pubmed/34063733
http://dx.doi.org/10.3390/vaccines9050453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147846/
https://www.ncbi.nlm.nih.gov/pubmed/34063733
http://dx.doi.org/10.3390/vaccines9050453

Ejemplares similares